Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome of activated mouse primary hepatic stellate cells treated with the OGT inhibitor OSMI-1

ABSTRACT: Transcriptome of activated mouse primary hepatic stellate cells treated with the OGT inhibitor OSMI-1

PROVIDER: PRJNA1016373 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome of activated mouse primary hepatic stellate cells treated with the OGT inhibitor OSMI-1

Project description:RNA-seq analysis of mouse primary myofibroblastic hepatic stellate cells (pMF-HSCs) treated or not with OSMI-1 OGT inhibitor (OGTi).

2024-05-22 | GSE243106 | GEO

Transcriptome of human LX-2 hepatic stellate cells treated with the OGT inhibitor OSMI-1

Project description:Transcriptome of human LX-2 hepatic stellate cells treated with the OGT inhibitor OSMI-1

| PRJNA1016368 | ENA

Transcriptome of human liver cells and culture-activated hepatic stellate cells

Project description:The molecular determinants of a healthy human liver cell phenotype remain largely uncharacterized. In addition, the gene expression changes associated with activation of primary human hepatic stellate cells, a key event during fibrogenesis, remain poorly characterized. Here, we provide the transriptomic profile underpinning the healthy phenotype of human hepatocytes, liver sinusoidal endothelial cells (LSECs) and quiescent hepatic stellate cells (qHSCs) as well as activated HSCs (aHSCs) We assess the transcriptome for purified, non-cultured human hepatocytes, liver sinusoidal cells (LSECs) and quiescent hepatic stellate cells (qHSCs) as well as culture-activated HSCs (aHSCs). Hepatocytes (n=2 donors), LSECs (n=3), qHSCs (n=3) and in vitro activated HSCs (n=3; from the same donors as the qHSCs and LSECs) were used for this study.

2016-03-02 | E-GEOD-68000 | biostudies-arrayexpress

Transcriptome of human LX-2 hepatic stellate cells treated with the OGT inhibitor OSMI-1

Project description:RNA-seq analysis of human LX-2 cells treated or not with OSMI-1 OGT inhibitor (OGTi).

2024-05-22 | GSE243102 | GEO

Transcriptome of human liver cells and culture-activated hepatic stellate cells

2016-03-02 | GSE68000 | GEO

ATAC-seq analysis of quiescent and activated primary mouse hepatic stellate cells

Project description:Contrasting chromatin accessibility between activated and quiescent hepatic stellate cells to identify key gene networks for the activation process.

2023-10-11 | E-MTAB-12908 | biostudies-arrayexpress

RNA-seq analysis of quiescent and activated primary mouse hepatic stellate cells

Project description:Contrasting transcript expression between activated and quiescent hepatic stellate cells to identify key gene networks for the activation process.

2023-10-11 | E-MTAB-12909 | biostudies-arrayexpress

Transcription profiling by array of human growing and senescent activated hepatic stellate cells

Project description:Cellular senescence is an irreversible proliferative arrest and can be triggered in many cell types in response to diverse forms of cellular damage or stress. We used microarrays to compare gene expression profile between growing and senescent human activated hepatic stellate cells. Experiment Overall Design: Two separate preparation of activated hepatic stellate cells were treated with DNA damaging agent to induce senescence or vechicle to remain growing. Experiment Overall Design: RNA was extracted from both replications and used for hybridization on Affymetrix arrays to determine expression differences.

2008-08-29 | E-GEOD-11954 | biostudies-arrayexpress

CUT&Tag analysis of H3K9Me3 binding quiescent and activated primary mouse hepatic stellate cells

Project description:Contrasting H3K9Me3 binding site number and localisation between activated and quiescent hepatic stellate cells to identify regulation of gene repression.

2023-10-11 | E-MTAB-12907 | biostudies-arrayexpress

Transcriptomic analysis of primary human hepatic stellate cells undergoing TGFb mediated activation and JQ1 mediated attenuation of activation

Project description:Comparison of longitudinal transcriptomic profiles of activated human primary hepatic stellate cells to activated human primary hepatic stellate cells that are treated with anti-fibrotic inhibitor reveals inflammatory signaling as a key pathway that is modulated during pro-fibrotic activation and repressed during attenuation of fibrotic response.

2019-12-18 | GSE117329 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data